Key Points:

• Accelevation raised $540 million by pricing 30 million shares at $18, below its marketed $20 to $24 range, making the deal a direct test of investor willingness to fund AI-linked infrastructure at current market conditions.
• The September 30 IPO calendar lists eight expected pricing events, but much of the visible activity consists of ETFs, investment vehicles and trusts, leaving Accelevation and Ives Ultra AI Opportunities among the more meaningful capital-markets transactions.
• Oura’s decision to postpone its IPO one day before the scheduled window highlights the contrast between continued demand for selected AI-related offerings and broader caution toward new equity issuance amid higher yields and market uncertainty.

Accelevation Becomes the Market’s Main IPO Test

The U.S. IPO calendar shows eight expected pricing events for Wednesday, September 30, but the headline transaction is Accelevation Holdings’ Nasdaq debut under the ticker ACCV. The data-center infrastructure company raised $540 million through 30 million shares priced at $18, below its previously marketed $20 to $24 range. The pricing is significant because Accelevation operates directly within the AI infrastructure investment cycle, yet investors still required a discount to the company’s marketed range to complete the transaction.

A $540 Million Deal Comes With a Clear Valuation Signal

Accelevation’s final price represents a meaningful reset from the terms announced one week earlier. The company had initially targeted $600 million to $720 million based on 30 million shares at $20 to $24, with the midpoint implying roughly $4.9 billion of equity value.

At $18, the completed offering generated $540 million instead. Accelevation itself sold 10 million shares, while selling shareholders affiliated with Olympus Partners sold 20 million, making the transaction substantially secondary in nature. The structure means the transaction provided both new capital to the business and liquidity for an existing investor, rather than representing a pure primary capital raise.

The discount also matters because the company’s operating momentum is substantial. Accelevation generated $727 million of revenue for the 12 months ended June 30, 2026, while its backlog stood at approximately $1.1 billion. Revenue increased 147% in 2025 as demand expanded for data-center power distribution and related infrastructure.

AI Infrastructure Demand Does Not Eliminate Pricing Discipline

Accelevation’s business sits beneath the AI boom rather than directly producing AI software or chips. It supplies power distribution and white-space infrastructure to hyperscale, colocation, AI and cloud operators. That positioning gives the company exposure to continued data-center capital spending while also tying its growth prospects to the sustainability of that investment cycle.

The $18 pricing therefore provides an important market signal: strong secular demand for data-center infrastructure can coexist with tighter valuation discipline in the public markets. Reuters reported that rising bond yields and higher interest rates have been weighing on investor risk appetite as the IPO proceeds.

Ives Ultra Adds a Different AI Capital-Market Structure

Wednesday’s calendar also includes Ives Ultra AI Opportunities, which priced 20 million shares at $10 for a $200 million offering. The closed-end investment fund is designed to give public-market investors exposure to private AI companies and is expected to begin trading on the NYSE under IVAI.

Unlike Accelevation, IVAI is not an operating-company IPO. Its significance lies in the structure: public equity investors are being offered access to private AI exposure through a listed investment vehicle. The transaction adds another route through which AI demand is being packaged for public markets.

The IPO Window Faces a More Selective Test

The strongest counterpoint to Wednesday’s activity is Oura’s postponement. The smart-ring maker delayed its planned U.S. IPO on September 29, citing market uncertainty after marketing 50 million shares at $40 to $44. Reuters linked the decision to a more difficult backdrop involving higher bond yields, interest rates, geopolitical pressures and volatility in technology stocks.

That leaves the IPO market with a narrower test: whether companies tied to strong structural themes can still access capital, and at what valuation. Accelevation’s below-range pricing suggests investors remain willing to fund growth, but the terms increasingly matter as issuers confront a higher cost of capital and more selective demand.